BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28051802)

  • 1.  Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.
    Waseem D; Tushar P
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):133-139. PubMed ID: 28051802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for intrahepatic and perihilar cholangiocarcinoma: Current and future.
    Zheng SS; Yang Z; Wu YC
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):101-102. PubMed ID: 32165068
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
    Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.
    Mizuno T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Yamaguchi J; Nagino M
    Surg Today; 2017 Feb; 47(2):182-192. PubMed ID: 27194019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
    Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Azuma T; Itoh T; Ku Y; Zen Y
    Mod Pathol; 2017 Jul; 30(7):986-997. PubMed ID: 28338651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.
    Im JH; Choi GH; Lee WJ; Han DH; Park SW; Bang S; Choi HJ; Seong J
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2435-2445. PubMed ID: 33471185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma.
    Juntermanns B; Sotiropoulos GC; Radunz S; Reis H; Heuer M; Baba HA; Canbay A; Schuler M; Gerken G; Paul A; Kaiser GM
    Ann Surg Oncol; 2013 Jan; 20(1):277-84. PubMed ID: 22805862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
    Al Mahjoub A; Bouvier V; Menahem B; Bazille C; Fohlen A; Alves A; Mulliri A; Launoy G; Lubrano J
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):678-684. PubMed ID: 30633038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
    Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.
    Chinchilla-López P; Aguilar-Olivos NE; García-Gómez J; Hernández-Alejandro KK; Chablé-Montero F; Motola-Kuba D; Patel T; Méndez-Sánchez N
    Ann Hepatol; 2017; 16(4):565-568. PubMed ID: 28611259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
    Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
    J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for a new classification for perihilar cholangiocarcinoma based on tumour depth.
    Shinohara K; Ebata T; Shimoyama Y; Nakaguro M; Mizuno T; Matsuo K; Nagino M
    Br J Surg; 2019 Mar; 106(4):427-435. PubMed ID: 30675908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.
    Nakeeb A; Pitt HA; Sohn TA; Coleman J; Abrams RA; Piantadosi S; Hruban RH; Lillemoe KD; Yeo CJ; Cameron JL
    Ann Surg; 1996 Oct; 224(4):463-73; discussion 473-5. PubMed ID: 8857851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
    Nassour I; Mokdad AA; Porembka MR; Choti MA; Polanco PM; Mansour JC; Minter RM; Wang SC; Yopp AC
    Ann Surg Oncol; 2018 May; 25(5):1193-1201. PubMed ID: 29488187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.